Skip to Content

Potassium Acetate Injection

Last Updated: December 27, 2017
Status: Current

Potassium Acetate Injection

Products Affected - Description
  • Potassium acetate injection, Pfizer
    2 mEq/mL, 20 mL vial, 25 count (NDC 00409-8183-01)

Reason for the Shortage
    • American Regent has not had product available for several years. It is unclear if they will market potassium acetate again in the future.
    • Pfizer has potassium acetate on shortage due to manufacturing delays.
Available Products
  • Potassium acetate injection, Exela Pharma Sciences
    2 mEq/mL, 20 mL vial, 25 count (NDC 51754-2001-04)

 
Potassium acetate injection, Pfizer
2 mEq/mL, 50 mL vial, 25 count (NDC 00409-3924-51)

Estimated Resupply Dates

  • Pfizer has potassium acetate 2 mEq/mL 20 mL vials on back order and the company estimates a release date of mid-January 2018.

Updated

December 27 and 8, October 4, September 6, 2017, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide